Target intelligence / Profile preview

Chloride nucleotide-sensitive channel 1A (CLNS1A)

Target
CLNS1A
Molecular classification
Ion channel, Epigenetic regulator, Chaperone, Methylosome subunit
01

Overview

Chloride nucleotide-sensitive channel 1A (CLNS1A), also known as methylosome subunit pICln, is a multifunctional protein involved in regulating chloride ion flux for cell volume control, acting as part of ion channel activity in the plasma membrane, and serving as a chaperone for spliceosome assembly in the nucleus. It forms a methylosome complex with PRMT5 and MEP50 to modify Sm proteins, crucial for RNA splicing and genome stability. CLNS1A promotes cell proliferation and survival, modulates DNA repair pathways, and has been implicated in several oncogenic contexts, particularly by enhancing cellular resistance to chemotherapy through chloride channel activity and dysregulated methylation. High CLNS1A expression is correlated with poor prognosis and increased chemoresistance in cancers such as lung and breast cancer, and it is also involved in immune cell proliferation and autoimmunity. Therapeutic modulation remains challenging due to its essential cellular functions and wide involvement in critical cell processes.

Other names
Methylosome subunit pIClnCLCIIClnI(Cln)ClCIchloride conductance regulatory protein IClnchloride ion current inducer proteinreticulocyte pIClnCLNS1Bchloride channel regulatory proteinchloride channel, nucleotide sensitive 1A
02

Mechanism of action

Blockade of chloride channel activity to counteract drug resistance; Inhibition of protein-protein interaction with PRMT5/methylosome complex; Modulation of splicing machinery or epigenetic transcriptional activation

03

Biological functions

Chloride ion flux and homeostasisRegulation of cell volumeAssembly and methylation of spliceosomal small nuclear ribonucleoproteins (snRNPs)Cell cycle progression and genome stabilityPlatelet activation and cytoskeletal organizationRegulation of gene expression, especially DNA repair and replication
04

Disease associations

Cancer (including lung, breast, prostate, and glioma)ChemoresistanceAutoimmune diseases (e.g., multiple sclerosis, inflammatory bowel disease)
05

Safety considerations

Essential for cell viability; broad inhibition could impair normal cell function and hematopoiesisEffects on immune cell proliferation and genome integrity
06

Interacting drugs

No directly approved drugs, but PRMT5 inhibitors may indirectly affect its methylosome complex

1 more in the full profile.

07

Biomarkers

Overexpression associated with poor prognosis in lung and breast cancerPotential predictive/prognostic biomarker for platinum drug resistanceExpression in autoimmune pathologies

Beyond the preview

Go deeper on Chloride nucleotide-sensitive channel 1A (CLNS1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride nucleotide-sensitive channel 1A (CLNS1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call